Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNγ or IL-12

Vaccine

Volumn 23, Issue 2, 2004, Pages 188-197

  Dale, C Jane ^a   De Rose, Robert ^a   Wilson, Kim M ^b   Croom, Hayley A ^b   Thomson, Scott ^c   Coupar, Barbara E H ^d   Ramsay, Alistair ^e   Purcell, Damian F J ^a   Ffrench, Rosemary ^f,g   Law, Matthew ^h   Emery, Sean ^h   Cooper, David A ^h   Ramshaw, Ian A ^c   Boyle, David B ^d   Kent, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c Biology and Environment   (Australia)

^d CSIRO   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f SYDNEY CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cytokine co expression; DNA; Macaque; Prime boost; Recombinant fowlpoxvirus; Vaccine

Indexed keywords

DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; POL PROTEIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; GENE EXPRESSION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MACACA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIRUS GENE;

AIDS VACCINES; ANIMALS; DNA, VIRAL; EVALUATION STUDIES; FOWLPOX VIRUS; HIV INFECTIONS; INTERLEUKIN-12; MACACA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 8644266843     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.05.024     Document Type: Article

References (37)

1. R.A. Koup, J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, and W. Borkowsky Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J. Virol. 68 7 1994 4650 4655
2. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, and M.A. Lifton Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 5403 1999 857 860
3. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.M. Fu, and W. Wagner Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination Science 290 5491 2000 486 492
4. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J. Virol. 72 12 1998 10180 10188
5. K.H. Leong, A.J. Ramsay, M.J. Morin, H.L. Robinson, D.B. Boyle, and I.A. Ramshaw Generation of enhanced immune responses by consecutive immunisation with DNA and recombinant fowlpox viruses F. Brown H. Chanock E. Norrby Vaccine 1995 Cold Spring Harbour Laboratory Press 327 331
6. H.L. Robinson, D.C. Montefiori, R.P. Johnson, K.H. Manson, M.L. Kalish, and J.D. Lifson Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant poxvirus booster immunizations Nat. Med. 5 5 1999 526 534
7. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
8. T.M. Allen, T.U. Vogel, D.H. Fuller, B.R. Mothe, S. Steffen, and J.E. Boyson Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen J. Immunol. 164 9 2000 4968 4978
9. E.G. Wee, S. Patel, A.J. McMichael, and T. Hanke A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques J. Gen. Virol. 83 Pt 1 2002 75 80
10. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
11. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, and G. Butcher Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 6 2003 729 735
12. D.H. Barouch, J. Kunstman, M.J. Kuroda, J.E. Schmitz, S. Santra, and F.W. Peyerl Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes Nature 415 6869 2002 335 339
13. T.U. Vogel, T.C. Friedrich, D.H. O'Connor, W. Rehrauer, E.J. Dodds, and H. Hickman Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J. Virol. 76 22 2002 11623 11636
14. E.S. Rosenberg, M. Altfeld, S.H. Poon, M.N. Phillips, B.M. Wilkes, and R.L. Eldridge Immune control of HIV-1 after early treatment of acute infection Nature 407 6803 2000 523 526
15. M.A. Liu DNA vaccines: a review J. Intern. Med. 253 4 2003 402 410
16. D.M. Klinman, A.K. Yi, S.L. Beaucage, J. Conover, and A.M. Krieg CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc. Natl. Acad. Sci. U.S.A. 93 7 1996 2879 2883
17. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 6813 2000 740 745
18. I.A. Ramshaw, M.E. Andrew, S.M. Phillips, D.B. Boyle, and B.E. Coupar Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection Nature 329 1987 545 546
19. K.H. Leong, A.J. Ramsay, D.B. Boyle, and I.A. Ramshaw Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus J. Virol. 68 12 1994 8125 8130
20. T.G. Terrell, and J.D. Green Comparative pathology of recombinant murine interferon-gamma in mice and recombinant human interferon-gamma in cynomolgus monkeys Int. Rev. Exp. Pathol. 34 Pt B 1993 73 101
21. R.T. Kenney, D.L. Sacks, J.P. Sypek, L. Vilela, A.A. Gam, and K. Evans-Davis Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis J. Immunol. 163 8 1999 4481 4488
22. S.J. Kent, A. Zhao, C.J. Dale, S. Land, D.B. Boyle, and I.A. Ramshaw A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques Vaccine 18 21 2000 2250 2256
23. C.J. Dale, A. Zhao, S.L. Jones, D.B. Boyle, I.A. Ramshaw, and S.J. Kent Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma J. Med. Primatol. 29 3-4 2000 240 247
24. J.L. Rossio, M.T. Esser, K. Suryanarayana, D.K. Schneider, Bess JWJ, and G.M. Vasquez Inactivation of HIV-1 infectivity with preservation of conformational and functional integrity of virion surface proteins J. Virol. 72 1998 7992 8001
25. S.J. Kent, C.J. Dale, S. Preiss, J. Mills, D. Campagna, and DF.J. Purcell Vaccination with Attenuated Simian Immunodeficiency Virus by DNA Inoculation J. Virol. 75 23 2001 11930 11934
26. S.J. Kent, A. Woodward, and A. Zhao Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with control of acute HIV-1 infection in macaques J. Infect. Dis. 176 5 1997 1188 1197
27. N.L. Letvin, D.C. Montefiori, Y. Yasutomi, H.C. Perry, M.E. Davies, and C. Lekutis Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination Proc. Natl. Acad. Sci. U.S.A. 94 17 1997 9378 9383
28. S. Lu, J. Arthos, D.C. Montefiori, Y. Yasutomi, K. Manson, and F. Mustafa Simian immunodeficiency virus DNA vaccine trial in macaques J. Virol. 70 6 1996 3978 3991
29. J.D. Boyer, B. Wang, K.E. Ugen, M. Agadjanyan, A. Javadian, and P. Frost In vivo protective anti-HIV immune responses in non-human primates through DNA immunization J. Med. Primatol. 25 3 1996 242 250
30. S.R. Lewin, M. Vesanen, L. Kostrikis, A. Hurley, M. Duran, and L. Zhang Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy J. Virol. 73 7 1999 6099 6103
31. L. Zhang, S.R. Lewin, M. Markowitz, H.H. Lin, E. Skulsky, and R. Karanicolas Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy J. Exp. Med. 190 5 1999 725 732
32. A.J. Ramsay, K.H. Leong, and I.A. Ramshaw DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors Immunol. Cell Biol. 75 4 1997 382 388
33. T. Hanke, T.J. Blanchard, J. Schneider, C.M. Hannan, M. Becker, and S.C. Gilbert Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime Vaccine 16 5 1998 439 445
34. T. Hanke, R.V. Samuel, T.J. Blanchard, V.C. Neumann, T.M. Allen, and J.E. Boyson Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen J. Virol. 73 9 1999 7524 7532
35. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, and C.M. Hannan Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat. Med. 4 4 1998 397 402
36. J.J. Kim, J.S. Yang, K.H. Manson, and D.B. Weiner Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants Vaccine 19 17-19 2001 2496 2505
37. Boyle DB, Anderson M-A, Amos R, Voysey R, Coupar BEH. Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules. Bio Techniques (in press).